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Biotin is a coenzyme composed of four carboxylases. It presents in amino acid 
catabolism, fatty acid synthesis, and gluconeogenesis. Biotinidase recycles 
the vitamin biotin. A biotinidase deficiency is a neurocutaneous disorder with 
autosomal recessive inheritance. The symptoms can be successfully treated 
or prevented by administering pharmacological doses of biotin. Although, 
according to neonatal prenatal medicine (2011), a biotinidase deficiency does 
not manifest during the neonatal period. In this study, we report on a case of 
biotinidase deficiency in the first week of birth.
Case Report
A 3100 g term boy was born via cesarean section. After 3 days, he was referred to 
the 17th Shahrivar Hospital with the chief complaint of tachypnea and grunting. 
Laboratory results revealed that liver and renal function tests, serum electrolytes, 
and blood indexes except ammonia were all normal. Within few days after the 
administration of oral biotin, the patient showed dramatic improvement and was 
discharged. However, within 4 months he was admitted two other times with 
the complaints of diarrhea and pneumonia. Unfortunately, he expired after 4 
months. 
 
According to our results, it seems that clinicians should accurately assess 
suspicious patients and even assess infants for biotinidase deficiency.
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Introduction 
Biotin is a coenzyme composed of four carboxylases. It is commonly present in 
amino acid catabolism, fatty acid synthesis, and gluconeogenesis (1, 2). Biotinidase 
deficiency (BD) is an autosomal recessive disorder that originates by a deficiency 
of the biotinidase enzyme. The incidence of combined (partial and profound) 
and profound BD were reported as 1 per 60,089 and 1 per 112,271 of live births, 
respectively (3). Biotinidase recycles the vitamin biotin. Although, BD has a 
fundamental influence on neurocutaneous organs and as a cause of neurological 
disorders, it is, however, indicated by symptoms that can be effectively treated 
or prevented with therapeutic doses of biotin. In addition, untreated BD can be 
mentioned as an ideal example of an inherited metabolic disorder that can induce 
major disabilities (3).  Although, most BD patients demonstrate metabolic ketolactic 
acidosis, organic aciduria, and mild hyperammonemia, it is asymptomatic in 
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In addition, CL and Na had been assessed and a high 
anion gap metabolic acidosis had been noted and was 
treated by 40 meq Hco3 (7.5%) or 13 meq/kg/day. 
According to parental interfamilial marriage and high 
anion gap metabolic acidosis, the clinicians decided to 
detect for metabolic disorders such as ammonia, lactate, 
tendon mass spectrum, and urine organic acid. 
Further, increased lactate and ammonia was observed. 
Our results showed abnormalities in the blood and urine. 
The presence of 3-hydroxyisovalerylcarnitine (C5-OH) 
and decreased biotinidase enzyme indicated BD. 
Within few days after administration of oral biotin (10 
mg / day), the patient showed dramatic improvement 
by normalization of blood gas analysis. Therefore, 
clinicians recommended discharge after 20 days.
However, within 4 months, he was admitted two other 
times with the complaints of diarrhea and pneumonia. 
Unfortunately, he expired after 4 months. 
 
Discussion
An infant with early presentation of BD was 
described. On admission, he had severe neurologic 
symptoms and by administering continuous biotin 
showed dramatic improvement. In addition, previous 
investigations recommended continued biotin therapy 
(8, 9). Unfortunately, on time and accurate diagnosis 
and treatments could not prevent further complications 
and the child expired after 4 months. It seems that it 
happened because of immunodeficiency combined with 
BD led to his expiration (10). 
In this study, we reported BD in the neonatal period. 
However, Zinn et al mentioned that BD does not manifest 
in the neonatal period (2), which is inconsistent with our 
results. Also, Andersen et al noted 2- and 3-weeks as the 
earliest reported age for BD (7). 
No complaint of seizure was mentioned in the current 
study. However, Venkataraman et al mentioned 
seizure as the presenting complaint in all patients and 
clonic seizure was the predominant seizure type (11). 
Moreover, Bunch et al mentioned that seizure was a 
common feature (55 % in Salbert series) and usually an 
initial symptom (38 %) in profound BD. They also noted 
generalized tonic–clonic (56 %) seizures (12). 
Moreover, in this study the patient had persistent 
severe metabolic acidosis, which was inconsistent with 
Venkataraman et al. In addition, Venkataraman et al 
noted acidosis in no patients (11). 
children without the presence of organic aciduria or 
metabolic ketoacidosis and the diagnosis of BD should 
be performed (4-6).  Recently, BD is indicated as a 
major criterion for newborn screening and is universally 
approved in the United States as well as other countries 
(3). BD can be detected by newborn screening or prenatal 
molecular analysis for mutations. Clinicians usually 
recommend prenatal molecular analysis in patients with 
previous familial affected child because of the discovery 
of carrier states (6) .
According to neonatal prenatal medicine, BD does not 
present in the neonatal period (2, 7). However, in this 
study, we report a case of BD in the first week after birth. 
 
Fig 1: A 3 days old boy who referred to hospital with 
the chief complaint of  tachypnea and grunting
Case Report  
A 3100 gram term boy was born through cesarean 
section. He was the second born child of consanguineous 
marriage and did not receive vaccinations at birth. Three 
days after birth, he was referred to 17th Shahrivar 
Hospital with a chief complaint of tachypnea and 
grunting. The anterior fontanel was not bulged and he 
was conscious but ill during the physical examination. 
He had grunting and intercostal retraction. A 2/6 systolic 
murmur at LSB was heard and based on the pediatric 
cardiologist examination; a heart abnormality was not 
mentioned.
O2 sat = 99%, RR = 58, PR = 156 
Laboratory studies revealed that liver and renal function 
tests, serum electrolytes, and blood indexes except 
ammonia were all normal (Table 1).
In addition, a sepsis workup including blood, urine, 
and CSF culture had been done and results indicated 
negative growth. Further, results indicated persistent 
severe metabolic acidosis based on ABG (pH: 7.01, Po2: 
169.4, Pco2: 20.4, Hco 3: 7, and O 2 sat 99 %). 
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Furthermore, in this study, results showed abnormality in 
both blood and urine 3-hydroxyisovalerylcarnitine (C5-
OH) and indicated BD. However, a previous investigation 
indicated increased blood 3-hydroxyisovalerylcarnitine 
(C5-OH) in beta-ketothiolase deficiency, 3methyl-
crotonyl-glycinuria, biotinidase deficiency, 
3-hydroxyisobutyric aciduria (13) As decreased levels 
of biotinidase enzyme by ELIZA in filter paper had been 
reported and may indicate a BD diagnosis, which should 
be confirmed by genetic methods.
In conclusion, according to our results, it seems that 
clinicians should accurately assess suspicious patients 
and even assess infants for BD.
 Table 1. Results of the laboratory tests 
Laboratory tests result Normal range
K 5.2 3.4–5.3 mmol /L
Na 137 137–147 mmol /L
Cl 102 99–108 mmol /L
Ca 9.5 8.7–10.7 mg /dL
Lactate 4 0.9–1.8 mmol /L
Ammonia 150 25-80 mmol /L
FBS 85 60–99 mg /dL
BUN 7 5–18 mg /dL
Cr 0.7 0.75–1.20 mg /dL
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